Weight Loss Programs May Boost Quality of Life for Breast Cancer Survivors

For many women diagnosed with breast cancer, the journey does not end with the final round of chemotherapy or radiation. Obesity and excess weight often follow diagnosis, bringing with them a higher risk of the cancer returning and a significant decline in daily well-being.

However, new research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting offers a practical and effective solution: a simple phone call.

Data from the Breast Cancer WEight Loss (BWEL) Trial, presented by Dr. Jennifer A. Ligibel of the Dana-Farber Cancer Institute, demonstrates that a telephone-based weight loss intervention can significantly improve physical function and overall quality of life for breast cancer survivors. Importantly, these benefits were not just short-term gains but were maintained over a full two-year period.

The hidden impact of weight in cancer care

The link between weight and breast cancer is well-documented but often overlooked in the rush to treat the tumor. Obesity is a poor prognostic factor for those with early-stage disease, meaning it is associated with a higher risk of the cancer spreading or proving fatal. Beyond the biological risks, excess weight is linked to reduced physical function, poor quality of life, and higher rates of side effects from life-saving treatments.

While scientists have long suspected that weight loss could help, the BWEL trial was designed to prove if a structured program could truly change how patients feel and function.

Inside the BWEL trial

The study was a massive undertaking, enrolling 3,180 participants with stage 2 or 3 breast cancer and a body mass index (BMI) of 27 or higher. Participants were split into two groups: one received standard health education, while the other received health education plus a two-year telephone-based weight loss program.

The intervention was designed to be accessible, allowing patients to receive coaching from the comfort of their homes. By the 12-month mark, those in the weight loss group had lost an average of 5.7% of their baseline weight, while those in the control group saw little change.

Moving better and feeling stronger

While the primary goal of the larger study is to see if weight loss prevents cancer from returning, a sub-study of 542 patients, the Health Outcomes (HO-1) group, focused specifically on how the program impacted daily life. This group was representative of the broader survivor community, with an average age of 53. The majority (roughly 81%) had undergone chemotherapy, and many were still taking endocrine therapy or had received radiation.

The results showed that by six months, the weight loss group experienced a statistically significant improvement in physical function compared to the control group. Patients reported that they were better able to perform daily tasks and move with greater ease.But the benefits were not just physical. The researchers found that the weight loss intervention led to significant boosts in:

• Global Physical Health: Overall bodily well-being.
• Global Mental Health: Emotional and psychological stability.
• Social Roles and Activities: The ability to participate in family and community life.
• Fatigue Reduction: A critical finding for cancer survivors who often struggle with chronic exhaustion.

Durability of the gains

Perhaps the most encouraging news for patients is that these improvements lasted. In many weight loss programs, the initial "honeymoon phase" is followed by a return to old habits and a decline in health metrics. However, the BWEL data showed that the favorable effects on physical function and mental health were sustained throughout the entire two-year intervention.

The study also tracked symptoms like anxiety, depression, sleep disturbance and pain interference. While the program did not significantly change anxiety or depression scores compared to the control group, the reduction in fatigue remained a standout benefit for those in the weight loss arm.

The road ahead

The BWEL trial is still ongoing, and the oncology community is awaiting the next set of data: whether this weight loss directly impacts invasive disease-free survival, or the likelihood of the cancer coming back.

For now, the message for patients is clear: addressing weight through a structured, supportive program can make the journey of survivorship easier.

Reference

1. “Effect of a weight loss intervention (WLI) on quality of life (QOL) and symptoms in women with breast cancer: Results from the Breast Cancer WEight Loss (BWEL) Trial” by Dr. Jennifer A. Ligibel at al., presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; May 29 – June 2, 2026; Chicago, IL. Abstract 12001.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.